Charlie's Holdings, INC 10-Q quarterly reports

Charlies Holdings, Inc. reported a significant increase in revenue for the first quarter of 2026, driven by strong sales in its nicotine-based and alternative alkaloid products, despite an overall net loss.

Charlies Holdings, Inc. reported a significant net income for Q3 2025, driven by a $7.5 million asset sale and strong early sales of its new SBX Metatine vape products, despite ongoing regulatory challenges and a 'going concern' warning.

Charlies Holdings, Inc. reported a significant net income for Q2 2025, driven by a $6.5 million asset sale, substantially improving its liquidity and working capital despite ongoing operational losses.

Charlie's Holdings, a producer of nicotine and alternative vapor products, reported a 24.4% revenue decrease and increased net loss for Q1 2025, but significantly improved its financial position through a $6.5 million asset sale to R.J. Reynolds Vapor Company post-period, addressing going concern doubts.

Charlies Holdings experienced a significant revenue decline in Q3 2024, alongside increased net losses and working capital deficits, while navigating a complex regulatory landscape.

Charlies Holdings experienced a significant revenue decline and net loss in Q2 2024, while navigating a complex regulatory landscape and ongoing concerns about its ability to continue as a going concern.

Charlies Holdings experienced a revenue decline and net loss in Q1 2024, while navigating a complex regulatory landscape and focusing on new product development.